July

July 28, 2016

Amino acid therapy for Diabetes mellitus: Taruine increases islet insulin levels, islet cell mass and glucose tolerance via down regulation of NMDA receptor GluN2A, 28/July/2016, 8.23 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Undisclosed information: How Taurine decreases the expression of NMDA receptor GluN2A Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ A study from the Institute of Metabolic Physiology, Heinrich Heine […]
July 28, 2016

Natural product-based therapy for Bone disorders: Genistein inhibits osteoporosis and bone metastasis via up regulation of its target gene, 28/July/2016, 7.45 am

A study from the Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA has reported that “miR-34a blocks osteoporosis and bone metastasis by inhibiting […]
July 26, 2016

Natural product-based Lifespan extension therapy: Berberine activates autophagy and extends lifespan via up regulation of ATG5, 26/July/2016, 8.44 am

A study from the Global Research Laboratory, Seoul National University, Korea shows that “Overexpression of Atg5 in mice activates autophagy and extends lifespan.” This study was published in the online […]
July 24, 2016

Interleukin therapy for Diabetes mellitus: IL-17 increases islet insulin levels, islet cell mass and glucose tolerance via down regulation of NMDA receptor GluN2A, 24/July/2016, 7. 04 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Undisclosed information: How IL-17 decreases the expression of NMDA receptor GluN2A Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ A study from the Institute of Metabolic Physiology, Heinrich Heine […]